November 13, 2020

Nashville Regional Healthcare Compliance Conference

Virtual , Central Standard Time (CST)

Registration closed
View all past conferences

Handouts

Overall Survey | CEU Application | Conference Brochure

OIG Update

Jason T. Bell Special Agent, Office of Inspector General U.S. Department of Health & Human Services

• Overview of national projects involving genetic testing, orthotics, and pharmacy fraud schemes
• Use of data analytics to identify health care fraud trends and target problem providers
• Developing successful partnerships with the compliance community

No Presentation Available
Evaluation

Compliance Year in Review

Anna Grizzle Partner, Bass Berry & Sims, PLC
Brian Roark Partner, Bass Berry & Sims, PLC

• Review the impact of COVID-19 on compliance issues, including an overview of waivers and other developments related to the pandemic
• Discuss 2020 enforcement actions and lessons learned from these matters
• Gain an understanding of expected trends and that may impact compliance efforts in 2021

Presentation
Evaluation

Managing Compliance to Overcome Chaos

Moderator
Jerod Holloway Managing Director, KPMG, LLP

Panel
LT Crozier Chief Compliance and Privacy Officer, NaviHealth, Inc.
Kathi Whalen Senior VP, Chief Ethics and Compliance Officer, HCA
Lisa Estrada Senior VP, Chief Compliance and Privacy Officer, LifePoint Health

• Discuss compliance challenges experienced during the pandemic
• Describe mechanisms for tracking constantly changing legal requirements and standards
• Discuss lessons learned for managing future crises

No Presentation Available
Evaluation

The Alignment or Misalignment of HIPAA and Part 2

Dan Devore Director, Corporate Privacy, CHS
Jaime Pego Managing Director KPMG, LLP

• Compare and contrast the HIPAA and Part 2 Regulations
• Discuss the Operational Differences between HIPAA and Part 2
• Review Case Studies

Presentation
Evaluation

Telehealth to the Rescue

Nesrin Tift Attorney Bass, Berry & Sims LLC
Cari Hollis Director, Telehealth, Access & Engagement LifePoint Health

Presentation
Evaluation

AseraCare and its Impact on the False Claims Act

Jack Selden Partner, Bradley Arant Boult Cummings, LLP
Kathryn Sasser Vice President, Litigation, HCA

• Understand FCA falsity in the context of medical necessity when the controlling guidance is based upon clinical judgment.
• Differentiate between the legal standards for FCA falsity set forth by the 11th Circuit in the Aseracare Hospice case and 3rd Circuit in the Care Alternatives case.
• Understand whether a court may hold that a physician’s clinical judgment can be false if both honestly held and reasonable.
• Understand when sub-regulatory agency guidance may be relied upon to prove FCA falsity after the Supreme Court opinion in Allina Health (June 2019).

Presentation
Evaluation

The Proposed Stark and AntiKickback Statute Regulatory Changes

Seema Kanwar Senior Associate General Counsel LifePoint Health
Scott Richardson VP, Associate General Counsel LifePoint Health

• Review the proposed rule changes to the federal Stark and Anti-kickback Statutes
• Discuss the impact of the proposed rule changes in the healthcare environment
• Consider how the proposed rule changes should inform a provider’s compliance program

Presentation
Evaluation